
The Killip-Kimball classification has played a fundamental role in classic cardiology, having been used as a stratifying criterion for many other studies. Mortality rate was found to be 38%.(current 30-day mortality 14.4) Mortality rate was found to be 17%.(current 30-day mortality 8.8) Mortality rate was found to be 6%.(current 30-day mortality 2.8) Within a 95% confidence interval the patient outcome was as follows: Killip class I: Nowadays, they have diminished by 30 to 50% in every class. Killip class IV describes individuals in cardiogenic shock or hypotension (measured as systolic blood pressure lower than 90 mmHg), and evidence of peripheral vasoconstriction ( oliguria, cyanosis or sweating).Killip class III describes individuals with frank acute pulmonary edema.Killip class II includes individuals with rales or crackles in the lungs, an S 3, and elevated jugular venous pressure.Killip class I includes individuals with no clinical signs of heart failure.Patients were ranked by Killip class in the following way: Patients with a cardiac arrest prior to admission were excluded. Ģ50 patients were included in the study (aged 28 to 94 mean 64, 72% male) with a myocardial infarction. The setting was the coronary care unit of a university hospital in the USA.
#STEMI SCORE SERIES#
The study was a case series with unblinded, unobjective outcomes, not adjusted for confounding factors, nor validated in an independent set of patients. Individuals with a low Killip class are less likely to die within the first 30 days after their myocardial infarction than individuals with a high Killip class. The Killip classification is a system used in individuals with an acute myocardial infarction (heart attack), taking into account physical examination and the development of heart failure in order to predict and stratify their risk of mortality.
